Cargando…
Management of Persistent Hypotony after Supraciliary CyPass(®) Implantation Using Argon Laser
PURPOSE: To report a case and management of persistent hypotony with hypotony-induced maculopathy after CyPass(®) device implant. BACKGROUND: The CyPass(®) was the first supraciliary ab interno device approved by FDA and commercially available. Efficacy studies showed adequate intraocular pressure (...
Autores principales: | Fernando, Del Valle-Nava, Díez-Cattini, GF, Alfonso, García-López, Francisco, Ortega-Santana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221243/ https://www.ncbi.nlm.nih.gov/pubmed/32431479 http://dx.doi.org/10.5005/jp-journals-10078-1259 |
Ejemplares similares
-
Ultrastructural analysis of explanted CyPass microstents and correlation with clinical findings
por: Hübner, Lisa, et al.
Publicado: (2022) -
Delayed bilateral hypertensive crisis with CyPass Micro-stent – The highs and lows
por: McCartney, Matthew, et al.
Publicado: (2020) -
CyPass(®) Micro-Stent Safety and Efficacy at One Year: What Have We Learned?
por: Gabbay, Itay E, et al.
Publicado: (2019) -
Comparing iStent versus CyPass with or without phacoemulsification in patients with glaucoma: a meta-analysis
por: Mahdavi Fard, Ali, et al.
Publicado: (2019) -
Comparing iStent versus CyPass with or without phacoemulsification in patients with glaucoma: a meta-analysis
por: Mahdavi Fard, Ali, et al.
Publicado: (2019)